Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
O
476040
vs
K
KOSPI 200
Over the past 12 months, OrganoidSciences Ltd has underperformed KOSPI 200, delivering a return of -81% compared to KOSPI 200's +125% growth.
Stocks Performance
476040 vs KOSPI 200
Performance Gap
476040 vs KOSPI 200
Performance By Year
476040 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
OrganoidSciences Ltd
Glance View
OrganoidSciences Ltd is a biotechnology company that builds organoid-based tools for drug discovery and disease research. Organoids are tiny lab-grown versions of human tissues, and the company uses them to help pharma companies and researchers test how drugs behave in a more realistic human-like model than simple cell cultures. The company makes money by selling research products, running testing and screening services, and developing organoid-related platforms that customers can use in their own labs. Its main customers are pharmaceutical companies, biotech firms, academic researchers, and other life-science groups that need better preclinical tools to study disease, compare drug candidates, and reduce reliance on animal testing. What makes the business different is that it sits between basic lab research and drug development. Instead of selling a finished medicine, OrganoidSciences sells the biological models and testing capability that help other companies make better decisions earlier in the development process. That gives it a role in the research supply chain rather than in direct patient care.